Lipitor sales top 31.1 billion won in first half

Published: 2012-07-19 06:59:00

Updated: 2012-07-19 06:59:00

Pfizer’s Lipitor posted 31.1 billion won in its first-half sales in domestic prescription drugs market, strengthening its supremacy as Korea’s leading anti-arteriosclerosis agent, according to data compiled by Yakup.com, a pharmaceutical information company.

The data showed that Dong-A’s Still...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK